Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or an alternative treatment
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]
Locations
8
United States
QuintilesIMS Plaza Building
Durham, North Carolina, United States
Fakultni nemocnice Kralovske Vinohrady
Prague, Czechia
Freiburg University Hospital/ Prof. Dr. med. Bodo Grimbacher
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Universitaetsklinikum Wuerzburg
Würzburg, Bavaria, Germany
Klinikum St. Georg GmbH
Leipzig, Saxony, Germany
Wojskowy Instytut Medyczny
Warsaw, Poland
Start Date
December 4, 2015
Primary Completion Date
December 17, 2019
Completion Date
December 17, 2019
Last Updated
April 28, 2021
Lead Sponsor
Baxalta now part of Shire
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions